NPPA panel fixes retail price of Zuventus antihypertensive FDC Efonidipine, telmisartan, details
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg manufactured and marketed by Zuventus Healthcare.
The retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare has been set at Rs 15.67 per tablet excluding GST
The recommendation came during the 39th meeting of the Multidisciplinary Committee of Experts held on February 25,2022, under the convenorship of Shri Manmohan Sachdeva, Advisor (Cost), through video-conferencing.
The issue of retail price fixation of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare Ltd under Para 5 of DPCO 2013 was analysed at the meeting.
Fixed-dosed combination regimen consisting of a Efonidipine Hydrochloride Ethanolate and Telmisartan represent a new addition to the available antihypertensive treatment options. This combination has a better efficacy, defined by time to reach blood pressure targets as well as levels of blood pressure achieved, compared with the individual drugs. The combination is well tolerated, including in patients with stage 2 hypertension and the elderly.
After detailed deliberation, the committee recommended that the retail price of each uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare at Rs 15.67 per tablet excluding GST as detailed below.
Computation of Retail Price per Tablet | Source/ Method | |
Composition-Each uncoated bilayered tablet containing Efonidipine Hydrochloride Ethanolate 40 mg + Telmisartan IP 40 mg | ||
a.Efonidipine Hydrochloride Ethanolate 40 mg(Calculated as per Para 4 of DPCO 2013) | Retail price(as per June,2021 data) | 10.38 |
B. Telmisartan IP 40 mg | Ceiling Price(as per notification no .1330€ dated 25th March,2021. | 6.61 |
Worked out Retail Price(a+b) | 16.99 | |
c.Less 20% of the lowest of (a) and (b) as recommended win the pronab Sen Committee report | 1.32 | |
Net Retail Price (a+b+c) (per tablet excluding GST) | 15.67 | |
Company Claimed Price excluding GST (per tablet) | 19.20 | |
Recommended price excluding GST (per tablet) | 15.67 |
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.